Aneira

Coming – August 5

Why Hair Loss Treatment Could Be The Next GLP-1

Date and Time

August 5

–

12:00 PM ET / 9:00 AM PT

Details will be provided upon RSVP approval

About this Event

GLP-1 medications have expanded beyond diabetes drugs to create a new generation of consumers willing to pay for therapies that improve not just health, but also confidence and appearance. Aneira Pharma believes hair restoration could become the next major aesthetic healthcare category.

More than 80 million Americans experience hair loss, with U.S. consumers spending over $3.5 billion annually on treatments with marginal efficacy. Globally, physician-directed hair loss therapies represent a market approaching $10 billion today and are projected to exceed $16 billion over the next decade. Despite this demand, innovation has remained limited, creating an opportunity for differentiated therapies.

Aneira’s lead product, ANR-001.1, combines minoxidil and latanoprost in a proprietary topical formulation designed to stimulate hair growth through complementary biological pathways. Unlike many competing therapies, it is designed for both men and women and addresses both scalp hair and eyebrow restoration.

The platform features:
  • Once-daily topical application
  • Favorable safety profile with low systemic exposure
  • Patent protection through at least 2040
  • Seven issued U.S. patents with protection in 58 countries

The company has completed Phase I and Phase IIa studies. According to company data, ANR-001.1 demonstrated meaningful improvements in hair count and thickness within 120 days, while its eyebrow product produced more than 50% improvement in brow density after three months of once-daily treatment.

Join our executive briefing with Aneira CEO, Dennis Fluet, to hear how hair restoration shares many of the same characteristics that made GLP-1s one of healthcare’s fastest-growing sectors in health care, including a massive underserved population, meaningful consumer demand, and therapies that improve both health and quality of life.

Sign Up Today

SHARE THIS EVENT

This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts and referenced statistics, contained in this presentation, including statements regarding future company strategy, operations, financial position, revenues, projected costs, plans and objectives of management, will be forward-looking statements.

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.